MARIANI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 9.859
NA - Nord America 458
AS - Asia 59
OC - Oceania 2
Totale 10.378
Nazione #
IT - Italia 9.692
US - Stati Uniti d'America 450
SE - Svezia 90
CN - Cina 20
IN - India 19
FI - Finlandia 13
NL - Olanda 12
DE - Germania 11
GB - Regno Unito 11
BE - Belgio 8
CA - Canada 7
ES - Italia 6
FR - Francia 5
IR - Iran 4
TH - Thailandia 4
UA - Ucraina 4
VN - Vietnam 4
GR - Grecia 3
HK - Hong Kong 3
AU - Australia 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
SG - Singapore 2
IL - Israele 1
MO - Macao, regione amministrativa speciale della Cina 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 10.378
Città #
Cagliari 9.628
Nyköping 79
Fairfield 72
Chandler 67
Ashburn 32
Houston 31
Wilmington 28
Cambridge 26
Seattle 24
Woodbridge 22
Boardman 19
San Diego 17
Boston 15
Helsinki 13
Pune 13
Rome 9
Amsterdam 8
Brussels 8
Toronto 7
Menlo Park 5
Pamplona 5
Beijing 4
Dearborn 4
Dong Ket 4
Hefei 4
Jacksonville 4
London 4
Nanjing 4
Naples 4
Islington 3
Peristeri 3
Ann Arbor 2
Centro 2
Chicago 2
Delhi 2
Don Mueang 2
Enna 2
Kyjov 2
Livorno 2
Norwalk 2
Paris 2
Romainville 2
San Francisco 2
San Mateo 2
Sydney 2
Xian 2
Zhengzhou 2
Alexandria 1
Amgaon 1
Ankara 1
Assèmini 1
Bergamo 1
Bilbao 1
Chandigarh 1
Exeter 1
Frattamaggiore 1
Gela 1
Heidelberg 1
Lecce 1
Lviv 1
Milan 1
Naaldwijk 1
Nanchang 1
Nanterre 1
New Bedfont 1
Olbia 1
Port-of-spain 1
Pozzuoli 1
Redwood City 1
Rockville 1
Sambuca di Sicilia 1
Shaoxing 1
Shenzhen 1
Sindelfingen 1
Somerville 1
South Deerfield 1
Stockholm 1
Tabriz 1
Torino 1
Totale 10.230
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 2.382
Molecular-biology-driven treatment for metastatic colorectal cancer 1.985
New therapeutic targets in pancreatic cancer 1.189
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.155
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 468
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 380
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 377
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 351
Uncovering key targets of success for immunotherapy in pancreatic cancer 313
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 262
Immune Checkpoint Inhibitors in the Treatment of HCC 255
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 253
BRCA-mutant pancreatic ductal adenocarcinoma 242
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers 240
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study 215
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 196
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 169
Totale 10.432
Categoria #
all - tutte 14.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201993 0 0 0 0 0 13 7 12 10 10 19 22
2019/2020893 47 19 6 12 254 210 182 35 20 33 23 52
2020/20213.495 69 102 66 1.186 649 407 144 235 102 224 185 126
2021/20221.575 100 73 19 72 69 105 77 140 103 168 290 359
2022/20233.544 359 512 414 287 331 360 189 204 203 219 272 194
2023/2024810 144 113 101 159 238 55 0 0 0 0 0 0
Totale 10.432